On September 2, 2026 Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, reported that Athena Countouriotis, M.D., Chair, President and CEO is scheduled to present and host investor meetings at the Wells Fargo 21st Annual Healthcare Conference taking place in Everett, Massachusetts from September 8–10, 2026.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details on the company’s participation are as follows:
Event: Presentation
Date: Wednesday, September 9, 2026
Presentation Time: 11:00 a.m. ET / 8:00 a.m. PT
A live webcast of the presentation will be accessible on the company’s website, www.avenzotx.com, under the News section and an archived recording will be available on the website for 90 days following the presentation.
(Press release, Avenzo Therapeutics, SEP 1, 2026, View Source [SID1234670528])